METABOLISMO ÓSEO, VASCULAR, ENFERMEDADES INFLAMATORIAS CRÓNICAS Y BIOMARCADORES
METOSEO
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institut d'Investigacions Biomèdiques August Pi i Sunyer (19)
2023
-
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
International Journal of Infectious Diseases, Vol. 137, pp. 134-143
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2020
-
Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study
BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1
2019
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis
Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
-
Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)
Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129
2016
-
Systemic activity and mortality in primary Sjögren syndrome: Predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients
Annals of the Rheumatic Diseases, Vol. 75, Núm. 2, pp. 348-355
2014
-
Analysis of ancestral and functionally relevant CD variants in systemic lupus erythematosus patients
PLoS ONE, Vol. 9, Núm. 11
-
Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study
Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114
-
Systemic involvement in primary Sjögren's syndrome evaluated by the EULAR-SS disease activity index: Analysis of 921 spanish patients (GEAS-SS registry)
Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 321-331
2013
-
Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es
Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863
-
Mediterranean diet adherence in individuals with prediabetes and unknown diabetes: The Di@bet.es study
Annals of Nutrition and Metabolism, Vol. 62, Núm. 4, pp. 339-346
-
Olive oil has a beneficial effect on impaired glucose regulation and other cardiometabolic risk factors. Di@bet.es study
European Journal of Clinical Nutrition, Vol. 67, Núm. 9, pp. 911-916
-
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: The di@bet.es study
Acta Diabetologica, Vol. 50, Núm. 4, pp. 615-623
2012
-
Evaluation of health-related quality of life according to carbohydrate metabolism status: A Spanish population-based study (Di@bet.es Study)
International Journal of Endocrinology, Vol. 2012
-
Iodine intake in the adult population. Di@bet.es study
Clinical Nutrition, Vol. 31, Núm. 6, pp. 882-888
-
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The Di@bet.es Study
Diabetologia, Vol. 55, Núm. 1, pp. 88-93